---
name: Veranex
slug: quartesian
site: cro
website_domain: veranex.com
summary: Veranex is an Innovation CRO uniting design, preclinical, clinical, regulatory, and market-access expertise for medical devices and diagnostics. The company accelerates development from concept through commercialization with integrated cross-disciplinary teams across 15 international hubs. Headquartered in Raleigh, United States.
tagline: The Innovation CRO accelerating medical device and diagnostic breakthroughs from concept to commercialization.
founded_year: 
employee_count_band: 1001-5000
employee_count_label: 1,001–5,000
parent_name: 
parent_slug: 
hq_country: US
tier2_domain_verified: false
updated_at: 2026-07-31T00:02:26.281Z
services_count: 18
modalities_count: 0
indications_count: 3
locations_count: 3
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Veranex

The Innovation CRO accelerating medical device and diagnostic breakthroughs from concept to commercialization.

Listed on cro.directory.

## Summary

Veranex is an Innovation CRO uniting design, preclinical, clinical, regulatory, and market-access expertise for medical devices and diagnostics. The company accelerates development from concept through commercialization with integrated cross-disciplinary teams across 15 international hubs. Headquartered in Raleigh, United States.

## At a glance

- Employees (est.): 1,001–5,000
- HQ country: US

## Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Clinical Trial Services
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Medical Writing
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Regulatory Affairs
- Pathology & Histology Services
- GLP Toxicology
- Preclinical In Vivo Studies
- Preclinical In Vitro Studies
- Cardiovascular & Metabolic Specialty Services
- CNS Specialty Services

## Indications

- Neurology
- Cardiovascular
- Ophthalmology

## Locations

- Headquarters, Raleigh, North Carolina, United States
- International Hub, London, United Kingdom
- International Hub, Bangalore, India

## Long description

## Overview

Veranex is positioned as the industry's first Innovation CRO (iCRO), consolidating product design, engineering, manufacturing, preclinical, clinical, regulatory, quality, and market-access expertise under one organization. The company serves over 700 global clients and has accelerated more than 1,000 programs, with approximately 800 cross-disciplinary experts across 15 international hubs.

## Core Service Areas

**Design & Development:** Product design, software development, engineering, testing, prototyping, human factors, and manufacturing solutions.

**Preclinical & Pathology:** Non-GLP and GLP preclinical studies, pathology services, surgical and bioskills training, cadaver lab facilities, and dedicated preclinical facilities.

**Clinical Research (CRO):** Trial design, trial management, project management, study monitoring, safety management, data management, biostatistics and statistical programming, data visualizations, and medical writing.

**Regulatory Consulting:** FDA device consulting, MDR consulting, IVDR consulting, and EU authorized representative services.

**Quality Consulting:** Audit and inspection readiness, QMS consulting, design validation and quality, and special process validation.

**Commercialization:** Innovation and strategy, market and customer insights, access and reimbursement, HEOR consulting, and integrated evidence planning.

## Therapeutic Expertise

Veranex maintains recognized leadership in cardiovascular, neurovascular, in-vitro diagnostics, and ophthalmology device development. The company also offers biopharma solutions and clinical trials support.

## Biostatistics Capabilities

The biostatistics team includes regulatory statistics experts with EMA experience and publication expertise in high-impact journals (The Lancet, PLoS, PNAS). Services extend beyond conventional clinical trial statistics to measurement theory, psychometrics, and patient-reported outcomes (PROs) consulting.

## Related companies

- [Lotus Clinical Research](/companies/lotuscr) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/lotuscr/quartesian)
- [Signant Health](/companies/signanthealth) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/quartesian/signanthealth)
- [ClinActis Pte Ltd](/companies/clinactis) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/clinactis/quartesian)
- [Clario](/companies/clario) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/clario/quartesian)
- [YPrime](/companies/yprime) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/quartesian/yprime)
- [Caidya](/companies/caidya) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/caidya/quartesian)
- [Advanced Clinical](/companies/advancedclinical) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/advancedclinical/quartesian)
- [PharPoint Research](/companies/pharpoint) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/pharpoint/quartesian)

_Profile last updated: 2026-07-31T00:02:26.281Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.